Cognivive, Inc.
1 known investors
Find your way into Cognivive, Inc.
Sign up to see every warm intro you have to Cognivive, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cognivive, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cognivive develops at-home virtual reality therapeutics that adapt in real time to patient performance, designed for patients to self-administer.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $299.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Cognivive, Inc. do?
- Cognivive develops at-home virtual reality therapeutics that adapt in real time to patient performance, designed for patients to self-administer.
- Who are Cognivive, Inc.'s investors?
- Cognivive, Inc.'s investors include Creative Destruction Lab (CDL).